ON THIS PAGE: You will learn about the different treatments doctors use for people with inflammatory breast cancer. Use the menu to see other pages.
This section tells you the treatments that are the standard of care for this type of cancer. “Standard of care” means the best treatments known. When making treatment plan decisions, patients are encouraged to consider clinical trials as an option. A clinical trial is a research study that tests a new approach to treatment. Doctors want to learn whether the new treatment is safe, effective, and possibly better than the standard treatment. Clinical trials can test a new drug, a new combination of standard treatments, or new doses of standard drugs or other treatments. Your doctor can help you consider all your treatment options. To learn more about clinical trials, see the About Clinical Trials and Latest Research sections.
In cancer care, doctors specializing in different areas of cancer treatment work together to create a patient’s overall treatment plan that combines different types of treatments. This is called a multidisciplinary team. Cancer care teams include a variety of other health care professionals, such as physician assistants, oncology nurses, social workers, pharmacists, counselors, nutritionists, and others.
Inflammatory breast cancer is considered a locally-advanced breast cancer and is typically treated with several types of treatment, including chemotherapy, surgery, radiation therapy, HER2 targeted therapy, and/or hormone therapy as appropriate. Treatment for inflammatory breast cancer usually starts with chemotherapy. Chemotherapy before surgery is called neoadjuvant or preoperative therapy. After chemotherapy, people with inflammatory breast cancer usually have surgery followed by radiation therapy to the breast or chest wall. If a patient has metastatic (stage IV) breast cancer when first diagnosed, the main treatment options are systemic therapies, such as chemotherapy. Surgery and/or radiation therapy are less commonly used.
Descriptions of common treatment options for inflammatory breast cancer are listed below. Treatment options and recommendations depend on several factors, including the type and stage of cancer, possible side effects, and the patient’s preferences and overall health. Your care plan may also include treatment for symptoms and side effects, an important part of cancer care. Take time to learn about all of your treatment options and be sure to ask questions about things that are unclear. Talk with your doctor about the goals of each treatment and what you can expect while receiving the treatment. Learn more about making treatment decisions.
Chemotherapy is the use of drugs to destroy cancer cells, usually by ending the cancer cells’ ability to grow and divide. Chemotherapy is given by a medical oncologist, a doctor who specializes in treating cancer with medication.
Systemic chemotherapy gets into the bloodstream to reach cancer cells throughout the body. Common ways to give chemotherapy include an intravenous (IV) tube placed into a vein using a needle or in a pill or capsule that is swallowed (orally).
A chemotherapy regimen, or schedule, consists of a specific treatment schedule of drugs given at repeating intervals for a set number of times. Chemotherapy for inflammatory breast cancer is usually given before surgery, called preoperative or neoadjuvant chemotherapy.
A patient may receive 1 drug at a time or combinations of different drugs given at the same time. Chemotherapy for inflammatory breast cancer that has not spread outside of the breast and regional lymph nodes usually includes a combination of drugs.
Common drugs for breast cancer may include:
Carboplatin (Carboplatin Hexal)
Cisplatin (available as a generic drug)
Cyclophosphamide (multiple names)
Docetaxel (Docefrez, Taxotere)
Doxorubicin (multiple names)
Pegylated liposomal doxorubicin (Doxil)
Methotrexate (multiple brand names)
Protein bound paclitaxel (Abraxane)
Common chemotherapy combinations for breast cancer may include:
AC (doxorubicin and cyclophosphamide)
AC or EC (epirubicin and cyclophosphamide or doxorubicin and cyclophosphamide) followed by T (paclitaxel or docetaxel)
CAF (cyclophosphamide, doxorubicin, and 5-FU)
CEF (cyclophosphamide, epirubicin, and 5-FU)
CMF (cyclophosphamide, methotrexate, and 5-FU)
EC (epirubicin, cyclophosphamide)
TAC (docetaxel, doxorubicin, and cyclophosphamide)
TC (docetaxel and cyclophosphamide)
Treatments that target the HER2 receptor may be given with chemotherapy for HER2-positive breast cancer (see Targeted therapy, below).
The side effects of chemotherapy depend on the individual and the drug and the dose used, but they can include fatigue, risk of infection, nausea and vomiting, hair loss, loss of appetite, and diarrhea. These side effects usually go away after treatment is finished. Rarely, long-term side effects may occur, such as heart damage, nerve damage, or secondary cancers, but studies have shown that these side effects typically do not shorten a patient’s life.
Learn more about the basics of chemotherapy and preparing for treatment. The medications used to treat cancer are continually being evaluated. Talking with your doctor is often the best way to learn about the medications prescribed for you, their purpose, and their potential side effects or interactions with other medications. Learn more about your prescriptions by using searchable drug databases.
Targeted therapy is a treatment that targets the cancer’s specific genes, proteins, or the tissue environment that contributes to cancer growth and survival. These treatments are very focused, and they work differently than chemotherapy. This type of treatment blocks the growth and spread of cancer cells while limiting damage to healthy cells.
Recent studies show that not all tumors have the same targets. To find the most effective treatment, your doctor may run tests to identify the genes, proteins, and other factors in your tumor. In addition, many research studies are taking place now to find out more about specific molecular targets and new treatments directed at them. Learn more about the basics of targeted treatments.
HER2 is a specialized protein found on breast cancer cells that controls cancer growth and spread. If an inflammatory breast cancer tests positive for HER2, the addition of targeted therapy to standard chemotherapy may be an option for treatment.
HER2-positive inflammatory breast cancer is usually treated with medications that target HER2. The choice of which HER2-targeted drug is used depends on the cancer’s stage.
Commonly used HER2-targeting medications include:
HER2-targeted therapy is usually given in combination with chemotherapy, and then after chemotherapy ends. Combination regimens for HER2-positive breast cancer may include:
ACTH (doxorubicin, cyclophosphamide, paclitaxel, trastuzumab)
TCH (docetaxel, carboplatin, trastuzumab)
THP (paclitaxel or docetaxel, trastuzumab, pertuzumab)
TCHP (docetaxel, carboplatin, trastuzumab, pertuzumab)
Patients receiving HER2-targeted therapies have a very small risk of developing heart problems. This risk is increased if a patient has other risk factors for heart disease. Heart problems do not always go away, but they are usually treatable with medication. Talk with your doctor about possible side effects for a specific medication and how they can be managed. Other targeted treatments are being tested in clinical trials; see the Latest Research section for more information.
Hormonal therapy, also called endocrine therapy, is an effective treatment for tumors that test positive for either estrogen or progesterone receptors (called ER-positive or PR-positive; see Introduction) in all stages of breast cancer. This type of tumor uses hormones to fuel its growth. Blocking the hormones may slow the growth of the tumor and destroy the cancer cells. Hormone therapy is typically recommended for hormone receptor-positive cancer after chemotherapy and radiation therapy or as treatment for metastatic breast cancer.
Hormonal therapy is usually taken for at least 5 years. Research shows that taking hormonal therapy for up to 10 years may be better than 5 years, especially for higher-risk tumors. How long to continue hormonal therapy depends on the stage of cancer, the risk of it returning, and any side effects you are experiencing.
Hormonal therapy for inflammatory breast cancer is typically started either during or after adjuvant radiation therapy (see below). Hormonal therapy options include:
Tamoxifen (Nolvadex, Soltamox) blocks estrogen from binding to breast cancer cells. It is a hormonal therapy that can be used by women who have been through menopause and women who have not.
Aromatase inhibitors decrease the amount of estrogen made by the body. This type of treatment is effective in treating breast cancer in postmenopausal women.
Ovarian suppression refers to the use of drugs or surgery to stop the ovaries from producing estrogen. It may be used in addition to another type of hormonal therapy for women who have not been through menopause. There are 2 methods used for ovarian suppression:
Drugs called gonadotropin or luteinizing releasing hormone (GnRH or LHRH) analogs that stop the ovaries from making estrogen. Goserelin (Zoladex), leuprolide (Lupron), and triptorelin (Trelstar) are GnRH and LHRH agonists that stop the ovaries from making estrogen for 1 to 3 months.
Surgery to remove the ovaries, which also stops estrogen production. However, this is permanent.
Fulvestrant (Faslodex) is a drug that is given by injection once a month. It is used to treat metastatic breast cancer. It stops estrogen from helping a cancer grow in a way that is different from tamoxifen.
Side effects of hormonal therapy can include hot flashes, decreased sexual desire or ability, and mood swings. Find additional information about hormone therapy in the breast cancer treatment section.
Surgery for breast cancer involves the removal of the tumor in an operation. Surgery is also used to examine the surrounding axillary or underarm lymph nodes. A surgical oncologist is a doctor who specializes in treating cancer using surgery.
Because inflammatory breast cancer is usually located throughout the breast and the lymphatic vessels in the skin, starting with surgery first may not be successful to remove the entire tumor with negative margins. A negative margin means that there is no cancer left at the edges of the tissue removed during surgery. Any cancer left behind during surgery increases the chances of recurrence in the breast and affects healing. So, chemotherapy is typically given first for inflammatory breast cancer to shrink and destroy the cancer in the breast, improving the chance that surgery will be successful.
The usual surgical treatment for inflammatory breast cancer is the removal of the entire breast, a procedure called a mastectomy. Reconstructive surgery of the breast after mastectomy is discussed below.
Before surgery, talk with your health care team about the possible side effects from the specific surgery you will have. Learn more about the basics of cancer surgery.
Lymph node removal and analysis
Cancer cells may be found in the axillary lymph nodes in some cancers. It is important to find out whether any of the lymph nodes near the breast contain cancer. This information is used to determine treatment and prognosis.
Sentinel lymph node biopsy. In a sentinel lymph node biopsy, the surgeon finds and removes a small number of lymph nodes from under the arm that receive lymph drainage from the breast. The pathologist then examines these lymph nodes for cancer cells. In general, sentinel lymph node biopsy is not appropriate for inflammatory breast cancer, and an axillary lymph node dissection, see below, is preferred.
Axillary lymph node dissection. In an axillary lymph node dissection, the surgeon removes many lymph nodes from under the arm. Then, a pathologist examines these lymph nodes for cancer cells. The actual number of lymph nodes removed varies from person to person. An axillary lymph node dissection is the preferred way to evaluate the axillary lymph nodes of a person with inflammatory breast cancer.
Reconstructive or plastic surgery
Women who need a mastectomy may wish to consider breast reconstruction, which is surgery to rebuild the breast. Breast reconstruction is performed by a reconstructive plastic surgeon.
There are many methods to reconstruct the breast. It may be done with tissue from another part of the body or with synthetic or artificial implants. Certain options may be preferred for inflammatory breast cancer because radiation therapy (see below) is almost always needed. Talk with your doctor for more information and learn more about reconstruction options.
Radiation therapy is the use of high-energy x-rays or other particles to destroy cancer cells. A doctor who specializes in giving radiation therapy to treat cancer is called a radiation oncologist. The most common type of radiation treatment is called external-beam radiation therapy, which is radiation given from a machine outside the body.
A radiation therapy regimen, or schedule, usually consists of a specific number of treatments given over a set period of time. Adjuvant radiation therapy is radiation treatment after surgery. It is effective in reducing the chance of breast cancer returning in both the breast and the chest wall. Adjuvant radiation therapy is nearly always recommended for people with inflammatory breast cancer after mastectomy, because of the high risk of cancer cells remaining in the chest wall. Neoadjuvant radiation therapy is radiation therapy given before surgery to shrink a large tumor. This can make the tumor easier to remove. However, neoadjuvant radiation therapy is rarely offered as part of breast cancer treatment.
Standard radiation therapy after a mastectomy is given to the chest wall for 5 days (Monday through Friday) for 5 to 6 weeks. Standard radiation therapy after a lumpectomy is external-beam radiation therapy given daily for 5 days per week (Monday through Friday) for 6 to 7 weeks. This usually includes radiation therapy to the whole breast first for 4 to 5 weeks, followed by a more focused treatment to the area where the tumor was located in the breast for the remaining treatments. This focused part of the treatment, called a boost, is standard for women with invasive breast cancer to reduce the risk of a recurrence in the breast.
If there is evidence of cancer in the underarm lymph nodes, radiation therapy may also be given to the lymph node areas in the neck or underarm near the breast or chest wall. There has been growing interest in newer radiation regimens to shorten the length of treatment from 6 to 7 weeks to periods of 3 to 4 weeks. However, these regimens have not been studied in people with inflammatory breast cancer. As always, patients should talk with their doctors about available options for radiation therapy, as well as the risks and benefits of these options.
Radiation therapy can cause side effects, including fatigue, swelling of the breast, and skin changes. Skin changes may include redness, discoloration, and pain or burning, sometimes with blistering or peeling. Very rarely, a small amount of the lung can be affected by the radiation, causing pneumonitis, a radiation-related inflammation of the lung tissue. This risk depends on the size of the area that received radiation therapy. However, this tends to heal with time. In the past, with older equipment and radiation therapy techniques, people who received treatment for breast cancer on the left side of the body had a small increase in the long-term risk of heart disease. Modern techniques are now able to spare most of the heart from the effects of radiation therapy.
Learn more about the basics of radiation therapy.
Getting care for symptoms and side effects
Cancer and its treatment often cause side effects. In addition to treatments intended to slow, stop, or eliminate the cancer, an important part of cancer care is relieving a person’s symptoms and side effects. This approach is called palliative or supportive care, and it includes supporting the patient with his or her physical, emotional, and social needs.
Palliative care is any treatment that focuses on reducing symptoms, improving quality of life, and supporting patients and their families. Any person, regardless of age or type and stage of cancer, may receive palliative care. It works best when palliative care is started as early as needed in the cancer treatment process. People often receive treatment for the cancer at the same time that they receive treatment to ease side effects. In fact, patients who receive both at the same time often have less severe symptoms, better quality of life, and report they are more satisfied with treatment.
Palliative treatments vary widely and often include medication, nutritional changes, relaxation techniques, emotional support, and other therapies. You may also receive palliative treatments similar to those meant to eliminate the cancer, such as chemotherapy, surgery, or radiation therapy. Talk with your doctor about the goals of each treatment in the treatment plan.
Before treatment begins, talk with your health care team about the possible side effects of your specific treatment plan and palliative care options. During and after treatment, be sure to tell your doctor or another health care team member if you are experiencing a problem so it can be addressed as quickly as possible. Learn more about palliative care.
Metastatic inflammatory breast cancer
If cancer has spread to another part in the body from where it started, it is called metastatic cancer. If this happens, it is a good idea to talk with doctors who have experience in treating it. Doctors can have different opinions about the best standard treatment plan. Also, clinical trials might be an option. Learn more about getting a second opinion before starting treatment, so you are comfortable with your chosen treatment plan.
Your treatment plan may include a combination of the treatments discussed above. However, surgery and radiation therapy may be used more often to manage symptoms in other parts of the body than to treat the cancer. Palliative care will also be important to help relieve symptoms and side effects.
For most patients, a diagnosis of metastatic cancer is very stressful and, at times, difficult to bear. Patients and their families are encouraged to talk about the way they are feeling with doctors, nurses, social workers, or other members of the health care team. It may also be helpful to talk with other patients, including through a support group.
Finishing treatment and the chance of recurrence
For patients with stage I, stage II, or stage III breast cancer, when treatment ends, a period many call post-treatment survivorship begins. After treatment, people can feel uncertain and worry that the cancer may come back. While many patients never have the disease return, it’s important to talk with your doctor about the possibility of the cancer returning. Understanding your risk of recurrence and the treatment options may help you feel more prepared if the cancer does return. Learn more about coping with the fear of recurrence.
If the cancer does return after the original treatment, it is called recurrent cancer. It may come back in the same place (called a local recurrence), nearby (locoregional recurrence), or in another place (distant recurrence or metastatic disease).
If this occurs, a new cycle of testing will begin again to learn as much as possible about the recurrence. After this testing is done, you and your doctor will talk about your treatment options. Often the treatment plan will include the treatments described above such as chemotherapy, surgery, and radiation therapy, but they may be used in a different combination or given at a different pace. Your doctor may suggest clinical trials that are studying new ways to treat this type of recurrent cancer. Whichever treatment plan you choose, palliative care will be important for relieving symptoms and side effects.
People with recurrent cancer often experience emotions such as disbelief or fear. Patients are encouraged to talk with their health care team about these feelings and ask about support services to help them cope. Learn more about dealing with cancer recurrence.
If treatment doesn’t work
Recovery from breast cancer is not always possible. If the cancer cannot be cured or controlled, the disease may be called advanced or terminal.
This diagnosis is stressful, and for many people, advanced cancer may be difficult to discuss. However, it is important to have open and honest conversations with your doctor and health care team to express your feelings, preferences, and concerns. The health care team is there to help, and many team members have special skills, experience, and knowledge to support patients and their families. Making sure a person is physically comfortable and free from pain is extremely important.
Patients who have advanced cancer and who are expected to live less than 6 months may want to consider a type of palliative care called hospice care. Hospice care is designed to provide the best possible quality of life for people who are near the end of life. You and your family are encouraged to talk with the health care team about hospice care options, which include hospice care at home, a special hospice center, or other health care locations. Nursing care and special equipment can make staying at home a workable option for many families. Learn more about advanced cancer care planning.
After the death of a loved one, many people need support to help them cope with the loss. Learn more about grief and loss.
The next section in this guide is About Clinical Trials. It offers more information about research studies that are focused on finding better ways to care for people with cancer. You may use the menu to choose a different section to read in this guide.